Baltic Medica - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 390,790 | 1,352,767 | 1,468,985 | 1,000,857 | 1,501,651 | 1,247,392 | 1,074,032 | 1,647,107 |
| Profit before tax | 91,684 | 220,214 | 299,295 | 106,281 | 319,897 | 57,804 | 83,800 | 247,352 |
| Net profit | 79,138 | 187,077 | 253,096 | 91,235 | 270,833 | 49,221 | 70,508 | 212,373 |
| Equity | 39,177 | 46,253 | 149,348 | 240,583 | 431,416 | 268,872 | 359,161 | 442,122 |
| Liabilities | 149,647 | 810,398 | 451,419 | 475,250 | 454,896 | 611,870 | 594,507 | 531,776 |
| Non-current assets | 3,516 | 5,939 | 129,623 | 15,104 | 20,100 | 17,490 | 9,570 | 7,496 |
| Current assets | 185,308 | 850,712 | 471,144 | 700,729 | 862,238 | 859,278 | 940,124 | 966,402 |
| Total assets | 188,824 | 856,651 | 600,767 | 715,833 | 882,338 | 876,768 | 949,694 | 973,898 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 220,598 | 177,993 | 236,983 |
| Social insurance contributions | - | - | - | - | - | 49,241 | 54,690 | 52,372 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +5.9% | +246.2% | +8.6% | -31.9% | +50.0% | -16.9% | -13.9% | +53.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 41.9% | 21.8% | 42.1% | 12.7% | 30.7% | 5.6% | 7.4% | 21.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 202.0% | 404.5% | 169.5% | 37.9% | 62.8% | 18.3% | 19.6% | 48.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 20.3% | 13.8% | 17.2% | 9.1% | 18.0% | 3.9% | 6.6% | 12.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 23.5% | 16.3% | 20.4% | 10.6% | 21.3% | 4.6% | 7.8% | 15.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 3.8 | 17.5 | 3.0 | 2.0 | 1.1 | 2.3 | 1.7 | 1.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 37,218 | 104,059 | 124,140 | 81,703 | 117,012 | 90,719 | 78,111 | 114,250 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Baltic Medica - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-10-17 | 2023-10-26 | 738.37 |
Baltic Medica - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-06-18 | 2025-06-18 | 173.74 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Baltic Medica, UAB (code 302725349) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, revenue reached €1.65M and net profit was €212.4K, resulting in a 12.9% profit margin. This followed a strong improvement from 2024, when revenue was €1.07M and net profit €70.5K, after 2023 revenue of €1.25M and net profit of €49.2K. The 2025 revenue growth was +53.4% year on year and +32.0% over two years, indicating a clear return to growth after the 2024 decline in turnover. Profitability strengthened even more sharply than sales, with profit before tax rising to €247.4K in 2025 from €83.8K in 2024. At year-end 2025, total assets stood at €973.9K, equity at €442.1K and liabilities at €531.8K. Key ratios show solid operating efficiency, including ROE of 48.0%, ROA of 21.8%, debt-to-equity of 1.20 and asset turnover of 1.69x. Revenue per employee was €117.7K and profit per employee €15.2K.